Skip to main content

Advertisement

Log in

Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

The purpose of this study is to compare the effectiveness of oxybutynin, functional electrostimulation (FES), and pelvic floor training (PFT) for treatment of women with detrusor overactivity. Sixty-four subjects were randomized to oxybutynin (n = 22), FES (n = 21), or PFT (n = 21). Women were evaluated before and after completion of 12 weeks of treatment by subjective response, voiding diary, and urodynamic test. There was subjective symptomatic improvement in 77% of the women treated with oxybutynin, 52% with FES, and 76% with PFT. Urgency resolved in 64% of women treated with oxybutynin, 52% with FES, and in 57% with PFT. Urodynamic evaluation was normal in 36% treated with oxybutynin, 57% with FES, and 52% with PFT. Maximum detrusor involuntary contraction pressure decreased in all groups (p < 0.05). All treatments were equally effective. Subjective reduction of urge-incontinence episodes was associated with symptomatic improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178

    Article  PubMed  Google Scholar 

  2. Staskin DR (2005) Overactive bladder in the elderly. A guide to pharmacological management. Drugs Aging 22(12):1013–1028

    Article  PubMed  CAS  Google Scholar 

  3. Hu TW, Wagner TH, Bentkover JD, Leblanc K, Piancentini A, Stewart WF, Corey R, Zhou SZ, Hunt TL (2003) Estimated economic costs of overactive bladder in the United States. Urology 61(6):1123–1128

    Article  PubMed  Google Scholar 

  4. Hay-Smith J, Herbison P, Ellis G, Moore K (2002) Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev 3:CD003781

    PubMed  Google Scholar 

  5. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JOL, Klarskov P, Shull BL, Smith ARB (1996) The standardization of terminology of female pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17

    Article  PubMed  CAS  Google Scholar 

  6. Chu FM, Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119(3A):3S–8S

    Article  CAS  Google Scholar 

  7. Ouslander JG (2004) Management of overactive bladder. N Engl J Med 350(8):786–797

    Article  PubMed  CAS  Google Scholar 

  8. Freeman RM (2005) How urgent is urgency? A review of current methods of assessment. Int Urogynecol J Pelvic Floor Dysfunct 16:93–95

    Article  PubMed  CAS  Google Scholar 

  9. Cannon TW, Chancellor MB (2002) Pharmacotherapy of the overactive bladder and advances in drug delivery. Clin Obstet Gynecol 45(1):205–217

    Article  PubMed  Google Scholar 

  10. Davila GW, Neimark M (2002) The overactive bladder: prevalence and effects on quality of life. Clin Obstet Gynecol 45(1):173–181

    Article  PubMed  Google Scholar 

  11. Burgio KL, Locher JL, Goode PS, Hardin JM, Mc Dowell BJ, Dombrowski M, Candib D (1998) Behavioral vs drug treatment for urge urinary incontinence in older women. A randomized controlled trial. JAMA 280:1995–2000

    Article  PubMed  CAS  Google Scholar 

  12. Burgio KL (2002) Influence of behavior modification on overactive bladder. Urology 60(suppl 5A):72–77

    Article  PubMed  Google Scholar 

  13. Yamanishi T, Yasuda K, Sakakibara R, Hattori T (2000) Randomized, double-blind study of electrical stimulation for urinary incontinence due to detrusor overactivity. Urology 55(3):353–357

    Article  PubMed  CAS  Google Scholar 

  14. Wein AJ (1998) Pharmacological options for the overactive bladder. Urology 51:43–47

    Article  PubMed  CAS  Google Scholar 

  15. Andersson KE, Yoshida M (2003) Antimuscarinics and the overactive detrusor: which is the main mechanism of action. Eur Urol 43:1–5

    Article  PubMed  CAS  Google Scholar 

  16. Fall M (1984) Does electrostimulation cure urinary incontinence. J Urol 131:664–667

    PubMed  CAS  Google Scholar 

  17. Fall M, Lindstrom S (1991) Electrical stimulation. A physiological approach to the treatment of urinary incontinence. Urol Clin North Am 18(2):393–407

    PubMed  CAS  Google Scholar 

  18. Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL (2002) Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. J Am Geriatr Soc 50:808–816

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raquel M. Arruda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arruda, R.M., Castro, R.A., Sousa, G.C. et al. Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women. Int Urogynecol J 19, 1055–1061 (2008). https://doi.org/10.1007/s00192-008-0586-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-008-0586-y

Keywords

Navigation